Alzheimer’s disease (AD) is all around us, with over 5 million
individuals diagnosed across the United States. Interestingly, of these 5
million Americans, over 3.5 million of them are women, suggesting women are
significantly more likely to suffer from AD than men.1,2 While AD is
best known for its impairment of memory, both short-term and long-term
depending on the extent of the illness, a variety of other symptoms may accompany
memory loss such as disorientation, confusion about time and place, changes in
mood and behavior, and difficulties with speech, eating, and walking. These
symptoms, collectively, lead to a significant loss in communication and
personal identity.
Low levels of sex hormones plays a significant role in the
onset of AD, and have led many scientists and doctors to propose Hormone
Replacement Therapy (HRT) as a potential treatment for this disease.4,5
While levels of sex hormones decrease with age, Alzheimer’s patients routinely
possess especially low levels of both testosterone and estrogen. Women see an
especially rapid, significant drop in sex hormone levels with menopause, which
subsequently leads to their significantly increased risk for developing AD. Both
estrogen and testosterone have been linked to cell proliferation and nerve protection,
and estrogen has been shown to increase cholinergic activity.4,5
Additionally, these hormones have been shown to suppress the effects of
beta-amyloid, a series of peptides which are involved in plaque formation and
the development of AD. Specifically, estrogen and testosterone prevent
beta-amyloid accumulation by increasing the activity of beta-amyloid-degrading
enzymes, and also protect against its neurotoxicity. Collectively, testosterone
and estrogen improve cognitive function and delay the progression and effects of
AD.4 Despite the clear importance of these two hormones, HRT has not
been accepted as a treatment of AD due to inconsistent results and a series of
serious side-effects, such as heart-attack, stroke, and an increased risk for
breast cancer and prostatic cancer.4
Recently, an article was published in the International Journal
of Alzheimer's Disease which links sex hormones with music therapy, and
thus proposes music therapy as an alternative to hormone replacement therapy.4
Stimulatory therapies, such as music therapy, have been extremely useful in the
management of AD for many individuals. I have personally witnessed the benefits
music can have on the mood and cognition of someone diagnosed with AD, and it
is widely accepted as an effective treatment both in neuroscientific blogs (BrainBlogger),
and the AD support community (Alz.org Blog).
While music therapy can have a wide variety of effects, scientific studies have
shown that music therapy moderates problematic behavior, improves social
involvement, promotes better cognition and awareness, increases brain
plasticity, and reduces levels of stress, anxiety and depression.6
Of course, it should be noted that this study’s methodology
is far from full-proof. With only six participants it can hardly be considered
an all-inclusive study, and Fukui et al. make no mention of how much music
therapy is needed before results are seen. Perhaps most importantly, the
authors fail to include how severe each patient’s AD was, leading to
questions about how effective this treatment will be at various stages of the
disease. However, despite these experimental flaws, I hope that this study encourages other researchers to
investigate music therapy as a natural alternative to hormone replacement therapy for Alzheimer’s
disease. While these studies are difficult, research on larger populations with
AD of varying severity as well as differences in exposure to music therapy are
necessary for the implementation of this treatment on a larger scale. Music therapy would be a fantastic treatment in that it is low-cost, non-invasive, and perhaps even enjoyable for these
patients who so badly deserve relief from their symptoms.
References:
1. Alzheimer's Association. (2014). 2014 Alzheimer's Disease Facts and Figures. Retrieved from: http://www.alz.org/downloads/facts_figures_2014.pdf2. Bao A., Swaab D.F. (2011). Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol, 32, 214-226.
3. Alzheimer's Association. (2014). What is Alzheimer’s? Retrieved from: http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp
4. Fukui H., Arai, A., Toyoshima, K. (2012). Efficacy of Music Therapy in Treatment for the Patients with Alzheimer’s Disease. Int J Alzheimers Dis, vol 2012.
5. Barron A.M., Pike, C.J. (2013) Sex hormones, aging, and Alzheimer’s disease. Front Biosci (Elite Ed), 4, 976-997.
6. Wollen, K. A. (2010). Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev, 15(3), 223-44; Sakamoto, M., Ando, H., & Tsutou, A. (2013). Comparing the effects of different individualized music interventions for elderly individuals with severe dementia. International Psychogeriatrics, 25(5), 775-784; Koger, S. M., Chapin, K., & Brotons, M. (1999). Is music therapy an effective intervention for dementia? A meta-analytic review of literature. Journal of Music Therapy, 36, 2-15.
No comments:
Post a Comment